Effects of CYP2C9 polymorphism on the pharmacokinetics of irbesartan in healthy Korean subjects

被引：0
|
作者：
Kim, Mi-Jung
Bae, Jung -Woo
Han, Ho-Kyun
Choi, Sun-Ok
Kim, Ok-Hee
Jang, Choon-Gon
Lee, Jin-Hee
Kim, Nam-Tae
Lee, Seok-Yong
机构：
[1] Sungkyunkwan Univ, Coll Pharm, Seoul, South Korea
[2] Natl Inst Toxicol Res, Seoul, South Korea
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
Irbesartan; CYP2C9; polymorphism; pharmacokinetics;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [41] Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
    Chang‑Keun Cho
    Ji-Young Byeon
    Pureum Kang
    Hye-Jung Park
    Eunvin Ko
    Chou Yen Mu
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Archives of Pharmacal Research, 2023, 46 : 111 - 116
  • [42] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Tan, Bo
    Zhang, Yi-Fan
    Chen, Xiao-Yan
    Zhao, Xiao-Hua
    Li, Guo-Xin
    Zhong, Da-Fang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (02) : 145 - 151
  • [43] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Bo Tan
    Yi-Fan Zhang
    Xiao-Yan Chen
    Xiao-Hua Zhao
    Guo-Xin Li
    Da-Fang Zhong
    European Journal of Clinical Pharmacology, 2010, 66 : 145 - 151
  • [44] Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data
    Makiko Kusama
    Kazuya Maeda
    Koji Chiba
    Akinori Aoyama
    Yuichi Sugiyama
    Pharmaceutical Research, 2009, 26
  • [45] Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data
    Kusama, Makiko
    Maeda, Kazuya
    Chiba, Koji
    Aoyama, Akinori
    Sugiyama, Yuichi
    PHARMACEUTICAL RESEARCH, 2009, 26 (04) : 822 - 835
  • [46] Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    Hyun-Jee Lee
    Young-Hoon Kim
    Se-Hyung Kim
    Choong-Min Lee
    Ae-Yun Yang
    Choon-Gon Jang
    Seok-Yong Lee
    Jung-Woo Bae
    Chang-Ik Choi
    Archives of Pharmacal Research, 2016, 39 : 1013 - 1019
  • [47] Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9*3 allele
    Shimamoto, J
    Ieiri, I
    Urae, A
    Kimura, M
    Irie, S
    Kubota, T
    Chiba, K
    Ishizaki, T
    Otsubo, K
    Higuchi, S
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (01) : 65 - 68
  • [48] Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    Lee, Hyun-Jee
    Kim, Young-Hoon
    Kim, Se-Hyung
    Lee, Choong-Min
    Yang, Ae-Yun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Bae, Jung-Woo
    Choi, Chang-Ik
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (07) : 1013 - 1019
  • [49] Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9*3 allele
    J. Shimamoto
    I. Ieiri
    A. Urae
    M. Kimura
    S. Irie
    T. Kubota
    K. Chiba
    T. Ishizaki
    K. Otsubo
    S. Higuchi
    European Journal of Clinical Pharmacology, 2000, 56 : 65 - 68
  • [50] PBPK modeling for irbesartan in different CYP2C9 genotypes
    Kang, Pureum
    Cho, Chang-Keun
    Ko, Eunvin
    Mu, Chou Yen
    Lee, Seok-Yong
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 249 - 250
12345